Azzurra Martini
Biographic Data
| ID | 7650820 |
|---|---|
| NAME | Azzurra Martini |
| GIVEN NAMES | Azzurra |
| FAMILY NAME | Martini |
| SIGNATURE | MARTINI A |
| AFFILIATIONS | Azienda Sanitaria Locale Roma 3 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD
This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings
Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series
Among individuals receiving an adequate pharmacological treatment for Major Depressive Disorder (MDD), only 30% reach a full symptom recovery; the remaining 70% will experience either a pharmacological response without remission or no response at all thus configuring treatment resistant depression (TRD). After an inadequate response to an antidepressant, possible next step options include optimizing the dose of the current antidepressant, switchi…
No prominent works on this page.
Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series
Among individuals receiving an adequate pharmacological treatment for Major Depressive Disorder (MDD), only 30% reach a full symptom recovery; the remaining 70% will experience either a pharmacological response without remission or no response at all thus configuring treatment resistant depression (TRD). After an inadequate response to an antidepressant, possible next step options include optimizing the dose of the current antidepressant, switchi…
Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD
This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings
Antidepressant (2 works) · Anxiety (2 works) · Internal Medicine (2 works) · Major depressive disorder (2 works) · Medicine (2 works) · Psychiatry (2 works) · Adverse effect (1 work) · Anesthesia (1 work) · Antipsychotic (1 work) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 work)